Shaoxian Wu

Changzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

IL21 is predominantly produced by a CXCL13 associated CD4+ T cell subset and shapes the immune microenvironment in colorectal cancer.

IL21 is predominantly produced by a CXCL13 associated CD4+ T cell subset and shapes the immune microenvironment in colorectal cancer.

Journal: Frontiers in immunology

Published: April 26, 2026

Colorectal cancer liver metastasis: immunosuppressive microenvironment, signaling pathways, and emerging therapeutic strategies.

Colorectal cancer liver metastasis: immunosuppressive microenvironment, signaling pathways, and emerging therapeutic strategies.

Journal: Frontiers in immunology

Published: April 14, 2026

Mechanistic insights into cordycepin-enhanced CTLA-4 blockade efficacy via Eubacterium rectale-mediated immunomodulation in colon cancer.

Mechanistic insights into cordycepin-enhanced CTLA-4 blockade efficacy via Eubacterium rectale-mediated immunomodulation in colon cancer.

Journal: International immunopharmacology

Published: December 29, 2025

CX3CR1 identifies a potent effector CD8+ T cell subset associated with anti-PD-1 therapeutic efficacy in colorectal cancer.

CX3CR1 identifies a potent effector CD8+ T cell subset associated with anti-PD-1 therapeutic efficacy in colorectal cancer.

Journal: Frontiers in immunology

Published: December 17, 2025

CD82-associated exhausted CD8+ T cells define prognosis and immunotherapy resistance in colon cancer.

CD82-associated exhausted CD8+ T cells define prognosis and immunotherapy resistance in colon cancer.

Journal: Frontiers in immunology

Published: October 23, 2025

IL-1β-mediated suppression of CIITA attenuates IFN-γ-induced MHC-II expression on Fibroblasts.

IL-1β-mediated suppression of CIITA attenuates IFN-γ-induced MHC-II expression on Fibroblasts.

Journal: Cell communication and signaling : CCS

Published: September 11, 2025

NK cells limit the synergistic anti-tumor effect of PD-1 inhibition and βγ-biased IL-2.

NK cells limit the synergistic anti-tumor effect of PD-1 inhibition and βγ-biased IL-2.

Journal: International journal of biological macromolecules

Published: July 25, 2025

IL-1R2 promotes tumorigenesis and modulates the tumor immune microenvironment in colorectal cancer.

IL-1R2 promotes tumorigenesis and modulates the tumor immune microenvironment in colorectal cancer.

Journal: Cancer immunology, immunotherapy : CII

Published: May 29, 2025

A Comprehensive Review of AIM2 in Cancer: Functional Roles, Molecular Pathways, and Clinical Relevance.

A Comprehensive Review of AIM2 in Cancer: Functional Roles, Molecular Pathways, and Clinical Relevance.

Journal: Journal of immunology research

Published: May 09, 2025

Identification of MAGE-A10 specific T cell receptor promising in immunotherapy of hepatocellular carcinoma.

Identification of MAGE-A10 specific T cell receptor promising in immunotherapy of hepatocellular carcinoma.

Journal: International journal of biological macromolecules

Published: March 20, 2025

Enhancing Colorectal Cancer Treatment Through VEGF/VEGFR Inhibitors and Immunotherapy.

Enhancing Colorectal Cancer Treatment Through VEGF/VEGFR Inhibitors and Immunotherapy.

Journal: Current treatment options in oncology

Published: February 17, 2025

Tregs ST2 deficiency enhances the abscopal anti-tumor response induced by microwave ablation.

Tregs ST2 deficiency enhances the abscopal anti-tumor response induced by microwave ablation.

Journal: International immunopharmacology

Published: August 19, 2024

Showing 1-12 of 36

Last Updated: 09/26/2026